Surgery Partners (SGRY) Competitors $20.58 +0.19 (+0.93%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$20.39 -0.19 (-0.92%) As of 08:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SGRY vs. GH, RDNT, BTSG, SHC, OPCH, WGS, HTFL, PRVA, VCYT, and CONShould you be buying Surgery Partners stock or one of its competitors? The main competitors of Surgery Partners include Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), Heartflow (HTFL), Privia Health Group (PRVA), Veracyte (VCYT), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. Surgery Partners vs. Its Competitors Guardant Health RadNet BrightSpring Health Services Sotera Health Option Care Health GeneDx Heartflow Privia Health Group Veracyte Concentra Group Holdings Parent Surgery Partners (NASDAQ:SGRY) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk. Which has preferable valuation and earnings, SGRY or GH? Surgery Partners has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Surgery Partners, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurgery Partners$3.11B0.85-$168.10M-$1.43-14.39Guardant Health$739.02M11.02-$436.37M-$3.35-19.50 Does the media refer more to SGRY or GH? In the previous week, Guardant Health had 2 more articles in the media than Surgery Partners. MarketBeat recorded 8 mentions for Guardant Health and 6 mentions for Surgery Partners. Guardant Health's average media sentiment score of 0.53 beat Surgery Partners' score of 0.06 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surgery Partners 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Guardant Health 1 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, SGRY or GH? Surgery Partners has a beta of 1.83, indicating that its share price is 83% more volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.53, indicating that its share price is 53% more volatile than the S&P 500. Is SGRY or GH more profitable? Surgery Partners has a net margin of -5.57% compared to Guardant Health's net margin of -49.93%. Surgery Partners' return on equity of 2.51% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Surgery Partners-5.57% 2.51% 1.01% Guardant Health -49.93%N/A -28.95% Do institutionals & insiders believe in SGRY or GH? 92.6% of Guardant Health shares are held by institutional investors. 2.7% of Surgery Partners shares are held by company insiders. Comparatively, 6.1% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Do analysts rate SGRY or GH? Surgery Partners presently has a consensus price target of $32.00, indicating a potential upside of 55.49%. Guardant Health has a consensus price target of $65.86, indicating a potential upside of 0.82%. Given Surgery Partners' higher probable upside, analysts clearly believe Surgery Partners is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surgery Partners 1 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.50Guardant Health 1 Sell rating(s) 0 Hold rating(s) 23 Buy rating(s) 0 Strong Buy rating(s) 2.92 SummarySurgery Partners beats Guardant Health on 9 of the 16 factors compared between the two stocks. Get Surgery Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SGRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SGRY vs. The Competition Export to ExcelMetricSurgery PartnersMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.61B$8.17B$6.09B$10.54BDividend YieldN/A2.83%5.69%4.71%P/E Ratio-14.3974.0085.6527.61Price / Sales0.8532.99538.60201.06Price / Cash10.8922.8037.9261.55Price / Book0.826.9712.966.76Net Income-$168.10M$247.60M$3.30B$275.88M7 Day Performance-2.92%1.11%4.32%2.81%1 Month Performance-6.20%0.75%9.47%9.24%1 Year Performance-30.68%13.32%84.27%35.42% Surgery Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SGRYSurgery Partners3.1985 of 5 stars$20.58+0.9%$32.00+55.5%-30.4%$2.61B$3.11B-14.3915,000News CoverageAnalyst ForecastGHGuardant Health3.5501 of 5 stars$63.38+0.9%$65.75+3.7%+210.3%$7.84B$739.02M-18.922,021Analyst ForecastRDNTRadNet3.1792 of 5 stars$78.29+0.8%$76.80-1.9%+12.9%$5.97B$1.83B-391.4311,021Positive NewsAnalyst ForecastBTSGBrightSpring Health Services2.8903 of 5 stars$28.87+1.8%$29.13+0.9%+92.5%$5.02B$11.27B38.3235,000News CoverageAnalyst ForecastSHCSotera Health2.6365 of 5 stars$16.22+1.7%$17.20+6.0%+3.9%$4.53B$1.10B202.783,000Positive NewsAnalyst ForecastOPCHOption Care Health4.8696 of 5 stars$27.33-0.6%$35.11+28.5%-3.6%$4.46B$5.00B21.868,088Positive NewsAnalyst ForecastWGSGeneDx2.2938 of 5 stars$120.19+1.6%$104.13-13.4%+125.8%$3.40B$305.45M2,403.801,200Analyst ForecastHTFLHeartflowN/A$37.28-1.0%$36.60-1.8%N/A$3.14BN/A0.00699PRVAPrivia Health Group3.7216 of 5 stars$24.13+0.2%$28.58+18.5%+43.6%$2.96B$1.74B219.381,140Positive NewsAnalyst ForecastVCYTVeracyte3.6824 of 5 stars$36.04+0.1%$40.90+13.5%+4.8%$2.83B$445.76M109.22790Analyst UpgradeInsider TradeCONConcentra Group Holdings Parent2.87 of 5 stars$20.65-0.5%$27.75+34.4%+5.5%$2.66B$1.90B17.3511,250Analyst Forecast Related Companies and Tools Related Companies Guardant Health Competitors RadNet Competitors BrightSpring Health Services Competitors Sotera Health Competitors Option Care Health Competitors GeneDx Competitors Heartflow Competitors Privia Health Group Competitors Veracyte Competitors Concentra Group Holdings Parent Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SGRY) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surgery Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
